No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use
-
Convalescence
-
Cytomegalovirus / drug effects
-
Cytomegalovirus / growth & development
-
Cytomegalovirus / immunology
-
Cytomegalovirus / pathogenicity*
-
Cytomegalovirus Infections / drug therapy
-
Cytomegalovirus Infections / immunology
-
Cytomegalovirus Infections / physiopathology*
-
Cytomegalovirus Infections / virology
-
Endoscopy, Digestive System
-
Esophagitis / drug therapy
-
Esophagitis / immunology
-
Esophagitis / physiopathology*
-
Esophagitis / virology
-
Female
-
Gastroesophageal Reflux / drug therapy
-
Gastroesophageal Reflux / immunology
-
Gastroesophageal Reflux / physiopathology*
-
Gastroesophageal Reflux / virology
-
Humans
-
Immunocompromised Host*
-
Kidney / immunology
-
Kidney / physiopathology
-
Kidney / surgery
-
Kidney / virology
-
Kidney Transplantation*
-
Middle Aged
-
Renal Insufficiency, Chronic / immunology
-
Renal Insufficiency, Chronic / physiopathology
-
Renal Insufficiency, Chronic / surgery
-
Renal Insufficiency, Chronic / virology
-
Valganciclovir / therapeutic use
Substances
-
Antiviral Agents
-
Valganciclovir